Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2017-10-18 2017-10-18
Drug Identification Number 02185377 02185377
Brand name BRETYLIUM TOSYLATE INJECTION USP BRETYLIUM TOSYLATE INJECTION USP
Common or Proper name BRETYLIUM BRETYLIUM
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients BRETYLIUM TOSYLATE BRETYLIUM TOSYLATE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 5 X 10ML VIALS 5 X 10ML VIALS
ATC code C01BD C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-07-03 2017-07-03
Estimated end date 2017-07-28 2017-07-28
Actual end date 2017-07-28 2017-07-28
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments